Highest percentage with mild, moderate, severe symptoms of anxiety or depression was seen for adults aged 18 to 29 years
Findings independent of other established risk factors
Cancer cases and deaths projected to nearly triple in low-HDI countries by 2050 compared with moderate increase in very high-HDI countries
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden
Age-adjusted CMM incidence rate was 0.99 per 1,000 from 2012 to 2016, marking an increase from previous years
Findings seen for incidence of overall and 14 site-specific cancers
Respiratory syncytial virus vaccination effective for adults aged at least 60 years
35 percent lower risk for diabetes, 20 percent reduced risk for hypertension seen for sugar restriction in first three years after conception
Women appear to be more affected than men, rural residents are more affected than city dwellers
Significant improvements seen in primary end points with T-TEER for patients with symptomatic, severe tricuspid regurgitation
Various standard clinical variables measured by clinicians analyzed to determine scope of machine learning techniques in predicting IDH